Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Foamix Pharmaceuticals Ltd (FOMX_old)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Foamix Pharma's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Foamix Pharma historical data, for real-time data please try another search
2.99 0.00    0.00%
06/03 - Closed. Currency in USD ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 2.90 - 3.44
Type:  Equity
Market:  United States
Foamix Pharma 2.99 0.00 0.00%

FOMX_old Recent Sentiments

 
User's sentiments regarding Foamix Pharma shares are displayed on both charts showing different time periods and in a detailed table.

Assess users' predictions on whether they expect FOMX_old shares to be bearish or bullish and add your investment views to the bearish or bullish futures discussion for Foamix Pharma.
Start Date Username Call Open Rate End Date Chg. %
Jan 21, 2020 Zoltán Deim   4.73 Feb 14, 2020 @ 4.42 -6.55%
Jan 09, 2020 Ioannis Kokkinias   3.72 Jan 31, 2020 @ 3.85 +3.49%
Dec 04, 2019 Aleksi Jurvanen   3.13 Dec 27, 2019 @ 3.35 +7.03%
Nov 26, 2019 Niko Brouwer   3.15 Dec 20, 2019 @ 3.29 -4.44%
Nov 11, 2019 Raúl Rooche   3.51 Dec 06, 2019 @ 3.06 -12.82%
Nov 11, 2019 Juan Fonseca   3.57 Dec 06, 2019 @ 3.06 -14.29%
Nov 11, 2019 sofian anouji   3.30 Dec 06, 2019 @ 3.06 +7.27%
Nov 11, 2019 Ayngaran Sivapathasun   3.22 Dec 06, 2019 @ 3.06 +4.97%
Nov 08, 2019 Ioannis Kokkinias   4.16 Nov 29, 2019 @ 3.18 -23.56%
Oct 29, 2019 Niro Fridman   3.01 Nov 22, 2019 @ 3.27 +8.64%
Oct 24, 2019 Peter Fogh   2.76 Nov 15, 2019 @ 3.41 +23.55%
Oct 17, 2019 Carlito Aniag   3.20 Nov 08, 2019 @ 4.34 +35.62%
Oct 16, 2019 Alesia Allen   3.05 Nov 08, 2019 @ 4.34 +42.30%
Oct 16, 2019 Jeremy Swainston   3.16 Nov 08, 2019 @ 4.34 -37.34%
Oct 16, 2019 David Fleisch   3.17 Nov 08, 2019 @ 4.34 +36.91%
Oct 10, 2019 Nawwar Hajj   2.85 Nov 01, 2019 @ 3.85 +35.09%
Oct 08, 2019 Niko Brouwer   2.57 Nov 01, 2019 @ 3.85 +49.81%
Sep 24, 2019 Peter Fogh   3.36 Oct 18, 2019 @ 3.16 -6.02%
Sep 03, 2019 francis Galgoci   2.92 Sep 27, 2019 @ 3.07 +5.14%
Aug 19, 2019 Peter Fogh   3.00 Sep 13, 2019 @ 3.50 +16.67%
Aug 13, 2019 Moreno Bocchio   3.15 Sep 06, 2019 @ 3.29 +4.44%
Jul 30, 2019 Matt Harbison   2.38 Aug 23, 2019 @ 3.37 +41.60%
Jul 30, 2019 Andrea Locatelli   2.45 Aug 23, 2019 @ 3.37 +37.55%
Jul 30, 2019 Francisco Santamaria   2.50 Aug 23, 2019 @ 3.37 -34.80%
May 10, 2019 Ng HUU   2.83 May 10, 2019 @ 2.81 +0.71%
Mar 07, 2019 Tzahi Katash   3.96 Mar 29, 2019 @ 3.75 -5.30%
Jan 09, 2019 Zoltán Deim   4.01 Feb 09, 2019 @ 4.41 +9.98%
Dec 06, 2018 מיכאל קדושים   4.20 Dec 11, 2018 @ 3.79 -9.76%
Dec 06, 2018 מיכאל קדושים   4.26 Dec 06, 2018 @ 4.24 -0.47%
Nov 12, 2018 Søren Kold   4.29 Dec 12, 2018 @ 4.41 +2.80%
Nov 12, 2018 שי כהן   4.28 Dec 12, 2018 @ 4.41 +3.04%
Nov 07, 2018 Errol Rackipov   4.54 Dec 07, 2018 @ 4.41 -2.86%
Sep 12, 2018 Petar Popovski   7.00 Oct 12, 2018 @ 4.41 -37.00%
Sep 07, 2018 נועם ברודסקי   5.89 Sep 26, 2018 @ 5.85 -0.68%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

FOMX_old Price Commentary

Write your thoughts about Foamix Pharmaceuticals Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email